Abstract:Michael Schachter is a primary care provider established in Suffern, New York and his medical specialization is family medicine. The NPI number of Michael Schachter is 1629199682 and was assigned on April 2007. The practitioners primary taxonomy code is 207Q00000X with license number 097295-1 (NY). The provider is registered as an individual and his NPI record was last updated 14 years ago.
Michael Schachter is a primary care provider established in Suffern, New York and his medical specialization is family medicine. The NPI number of Michael Schachter is 1629199682 and was assigned on April 2007. The practitioner's primary taxonomy code is 207Q00000X with license number 097295-1 (NY). The provider is registered as an individual and his NPI record was last updated 14 years ago.
A primary care provider (PCP) like Dr. Michael Ben Schachter Md sees people with common medical problems. The primary care provider might be a doctor, physician assistant, nurse practitioner or clinic that are usually involved in your long-term care. A PCP might provide preventive care, treat common medical conditions, identify urgent medical problems and refer you to specialists when necessary. Primary care is usually provided in an outpatient facility but if you are admitted to a hospital your PCP may assist in your care. The most common medical conditions seen by primary care providers are: hypertension, upper respiratory tract infections, depression or anxiety, back pain, arthritis, dermatitis, diabetes, urinary tract infections, etc
Michael Schachter is enrolled in PECOS and is eligible to order or refer healthcare services for Medicare patients. The provider is eligible to order or refer: Part B Clinical Laboratory and Imaging, Durable Medical Equipment (DME), a Home Health Agency (HHA) and Power Mobility Devices.
Michael Schachter is a non-participating provider of Medicare. If you are a Medicare beneficiary this means the provider can charge up to 15% more than Medicare's approved amount for the cost of rendered services, in addition to your normal deductible and coinsurance costs. There are some states that restrict the limiting charge when you see non-participating provider. If you pay the full cost of your care up front, your non- participating provider should still submit a claim to Medicare. Afterward, you should receive reimbursement from Medicare for up 80% of the Medicare-approved amount for the services rendered.
The provider doesn't accept Medicare and has signed an affidavit to be excluded from the Medicare program. If you are a Medicare beneficiary this means a provider can charge whatever they want for services rendered but must follow certain rules to do so. Michael Schachter opted out of Medicare effective on 01-01-2014 until 01-01-2022. Opt out periods last for two years and cannot be terminated unless the provider is opting out for the very first time and the affidavit is terminated no later than 90 days after the opt out effective date. Opt-out affidavits might renew automatically renew every two years. The provider opted out of Medicare but is permitted to order and refer services to other healthcare providers.
Mushroom extract: the focus of immune health new product development
Basedontheincreaseofconsumersawarenessofhealthandtheirdailymentalpressure,theplantrawmaterialproductswiththemainconcepto
CloseTo2021-04-28
After more than 40 years of research on diseases, academicians summed up 7 natural forces of human b
Tumortreatmentshouldbedividedintotwopartsandcombinedtreatment.Differentpeopleanddifferentcellgroupsshouldbeanalyzedsepar
iHealth2021-04-21
Anti-Diabetic and Anti-Nephritic Activities of Grifola frondosa Mycelium Polysaccharides in Diet-Str
Anti-DiabeticandAnti-NephriticActivitiesofGrifolafrondosaMyceliumPolysaccharidesinDiet-Streptozotocin-InducedDiabeticRat
Research2021-04-21
Qianxi, Hebei Province: small Maitake makes a big industry
Inrecentyears,QianxiCountyofHebeiProvincetakeschestnutmushroomindustryasanimportantindustrytodrivepeoplesincomeincrease,
CloseTo2021-04-15
AntitumoractivityandimmunefunctionofMaitakepolysac
Research2021-01-05
Maitakepolysaccharideanditsanticancereffect
Research2021-01-04
ImmunoregulationandantitumoractivityofMaitakepolys
Research2021-01-05
TheNationalCancerPreventionandcontrolpublicityweek
Reports2021-04-15
OnMarch28,2021,theprojectHealthChina2030-standardi
Reports2021-04-01
GB7096—2014IssuedonDecember24,2014Nationalfoodsaf
Reports2021-03-11
OntheafternoonofJune28,thenational"twofirst"recogn
CloseTo2021-07-01
Maitake,commonlyknownasWurong,isakindofpreciousfun
CloseTo2021-05-24
Nowadays,itsthebestseasonforMaitakecultivationinQi
CloseTo2021-05-19